Ignite Creation Date:
2024-10-26 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 3:35 PM
Study NCT ID:
NCT06511193
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-16
Brief Title:
Chronicling the COPD Patient Journey and Change in COPD Symptoms Quality of Life and Exacerbations Following Initiation of BudenosideGlycopyrroniumFormoterol BGF
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Chronicling the COPD Patient Journey and Change in Impact of a Single Inhaler Combination Therapy on COPD Symptoms Quality of Life and Exacerbations Following Initiation of BudenosideGlycopyrroniumFormoterol BGFCHRONICLES COPD
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CHRONICLES
Brief Summary:
The CHRONICLES study will investigate the change in clinical and patient reported outcomes after six-months of treatment with BudenosideGlycopyrroniumFormoterol BGF in a real-world setting
Detailed Description:
This is a prospective open label non-interventional single network of clinical practice centers study that will be conducted in routine clinical care in the pulmonary primary care practitioner PCP care setting in Ontario Canada Eligible patients will be enrolled into the study only following the treating physicians decision and patient agreement to initiate treatment with BGF Patients will be observed for up to 6 months post-treatment initiation with BGF
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None